Search results

Evidence-based recommendations on canagliflozin (Invokana), dapagliflozin (Forxiga) and empagliflozin (Jardiance) as options for treating type 2 diabetes in adults.

Result type

Technology appraisal guidance

Published

25 May 2016

Evidence-based recommendations on peginterferon alfa (Pegasys) and ribavirin for people with mild chronic hepatitis C.

Result type

Technology appraisal guidance

Last updated

27 November 2013

Evidence-based recommendations on necitumumab (Portrazza) for treating locally advanced or metastatic epidermal growth factor receptor (EGFR)-expressing squamous non-small-cell lung cancer in adults who have not had chemotherapy.

Result type

Technology appraisal guidance

Published

28 September 2016

Evidence-based recommendations on deucravacitinib for treating moderate to severe plaque psoriasis in adults.

Result type

Technology appraisal guidance

Published

28 June 2023

NICE is unable to make a recommendation on tisagenlecleucel (Kymriah) for treating relapsed or refractory diffuse large B-cell lymphoma in adults after 2 or more systemic therapies. This is because Novartis did not provide a complete evidence submission.

Result type

Technology appraisal guidance

Published

29 November 2023

Evidence-based recommendations on adalimumab (Humira) for treating active moderate to severe hidradenitis suppurativa in adults whose disease has not responded to conventional systemic therapy.

Result type

Technology appraisal guidance

Published

22 June 2016

clinical effectiveness and safety of differing doses of lipid-modifying therapy in children with FH? Any explanatory notes(if...

Result type

Research recommendation

Published

15 November 2019

Evidence-based recommendations on tocilizumab (RoActemra) for treating rheumatoid arthritis in adults.

Result type

Technology appraisal guidance

Published

22 February 2012

Evidence-based recommendations on eribulin (Halaven) for treating locally advanced or metastatic (secondary) breast cancer in adults who have had only 1 course of chemotherapy.

Result type

Technology appraisal guidance

Published

28 March 2018

Evidence-based recommendations on bevacizumab (Avastin), with paclitaxel and carboplatin, for treating advanced ovarian cancer in adults.

Result type

Technology appraisal guidance

Published

22 May 2013

Evidence-based recommendations on donepezil (Aricept), galantamine (Reminyl), rivastigmine (Exelon) and memantine (Ebixa) for treating Alzheimer's disease in adults.

Result type

Technology appraisal guidance

Last updated

20 June 2018

Evidence-based recommendations on ibrutinib (Imbruvica) for treating chronic lymphocytic leukaemia in adults.

Result type

Technology appraisal guidance

Published

25 January 2017

Evidence-based recommendations on percutaneous (non-thoracoscopic) epicardial catheter radiofrequency ablation for atrial fibrillation. This involves using heat to destroy selected areas of the heart to prevent the abnormal electrical impulses responsible for atrial fibrillation.

Result type

Interventional procedures guidance

Published

27 March 2009

This quality standard covers assessing, diagnosing and managing rheumatoid arthritis in over 16s. It describes high-quality care in priority areas for improvement.

Result type

Quality standard

Last updated

9 January 2020

Evidence-based recommendations on radium-223 dichloride (Xofigo) for treating hormone-relapsed prostate cancer with bone metastases in adults.

Result type

Technology appraisal guidance

Published

28 September 2016